Breaking News Instant updates and real-time market news.

TWTR

Twitter

$33.42

2.465 (7.96%)

15:38
02/13/18
02/13
15:38
02/13/18
15:38

Twitter's Dorsey says 'more work to be done,' but a lot of infrastructure fixed

  • 28

    Feb

  • 07

    Mar

TWTR Twitter
$33.42

2.465 (7.96%)

02/09/18
ARGS
02/09/18
NO CHANGE
Target $40
ARGS
Buy
Twitter price target raised to $40 from $30 at Argus
Argus analyst Jim Kelleher raised his price target on Twitter to $40 and kept his Buy rating after the company's Q4 earning beat. Kelleher cites company accelerating its EPS growth to mid-teens from single digits, expanding margins, and growing international revenue. The analyst sees the stock trading in line with peers on price/sales and EV/EBITDA valuation, recommending shares to "highly risk-tolerant investors".
02/09/18
RHCO
02/09/18
NO CHANGE
Target $29
RHCO
Hold
Twitter price target raised to $29 from $18 at SunTrust
SunTrust analyst Youssef Squali raised his price target on Twitter to $29 after improved monetization seen in the company's Q4 earnings, but says the flat MAU's and high valuation keeps his rating on Hold. Squali points to "growing user engagement and better cost containment leading to record high margins and free cash flow" and believes the momentum is likely sustainable as Twitter management improves the product and the ad platform to attract larger advertisers.
02/09/18
02/09/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Twitter (TWTR) upgraded to Sector Perform from Underperform at RBC Capital with analyst Mark Mahaney saying the fourth quarter revenue and EBITDA were materially better than expected, and while MAU's were below consensus, DAU's grew for the first time at a double-digit rate. 2. iRobot (IRBT) upgraded to Outperform from Market Perform at Raymond James with analyst Mark Strouse saying he sees a more balanced risk/reward following the recent pullback in the shares. 3. Regeneron (REGN) upgraded to Outperform from Neutral at Baird with analyst Brian Skorney noting its selloff since last year and believes its valuation has reached a point where the selloff is overdone. 4. Teva (TEVA) upgraded to Sector Perform from Underperform at RBC Capital with analyst Randall Stanicky saying the 11% sell-off in the stock price following the company's guidance update has removed the debate around 2018 EBITDA target and sees limited downside from the current levels. 5. United Technologies (UTX) upgraded to Buy from Hold at Argus with analyst John Eade saying the company remains a leader in a number of global industries and should continue to benefit from population growth and middle class expansion in developing markets. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/12/18
BMOC
02/12/18
NO CHANGE
Target $28
BMOC
Market Perform
Twitter price target raised to $28 from $22 at BMO Capital
BMO Capital analyst Daniel Salmon raised his price target on Twitter (TWTR) to $28 after Q1 results, saying the company has a "clearer strategy" to sustain its revenue momentum thanks to video and AI helping grow mainstream adoption. As top-line pressures fade, writes the analyst in his research note titled "Solid Steps Down Road to Recovery", the stock could become "more interesting", though he is also weary of Facebook (FB) competition still "looming large". Salmon keeps a Market Perform rating on Twitter.

TODAY'S FREE FLY STORIES

DYNT

Dynatronics

$2.65

-0.0296 (-1.10%)

08:10
02/21/18
02/21
08:10
02/21/18
08:10
Hot Stocks
Dynatronics CEO and President Kelvyn Cullimore stepping down »

Dynatronics CEO and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 11

    Mar

BLMN

Bloomin' Brands

$20.89

0.1 (0.48%)

08:10
02/21/18
02/21
08:10
02/21/18
08:10
Hot Stocks
Barington Capital urges changes at Bloomin' Brands to improve long-term value »

Barington Capital Group,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HD

Home Depot

$186.71

-0.26 (-0.14%)

08:10
02/21/18
02/21
08:10
02/21/18
08:10
Recommendations
Home Depot analyst commentary  »

Home Depot price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

FINL

Finish Line

$9.54

-0.61 (-6.01%)

08:07
02/21/18
02/21
08:07
02/21/18
08:07
Upgrade
Finish Line rating change  »

Finish Line upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLFD

Clearfield

$12.45

0.2 (1.63%)

, CALX

Calix

$6.80

-0.05 (-0.73%)

08:06
02/21/18
02/21
08:06
02/21/18
08:06
Hot Stocks
Clearfield acquires outdoor powered cabinet product portfolio from Calix »

Clearfield (CLFD) has…

CLFD

Clearfield

$12.45

0.2 (1.63%)

CALX

Calix

$6.80

-0.05 (-0.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 26

    Feb

MNTA

Momenta

$15.95

-0.1 (-0.62%)

08:06
02/21/18
02/21
08:06
02/21/18
08:06
Earnings
Momenta reports Q4 EPS 18c, may not compare to consensus (31c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

VYGR

Voyager Therapeutics

$23.66

4.3 (22.21%)

, ABBV

AbbVie

$117.98

-0.62 (-0.52%)

08:05
02/21/18
02/21
08:05
02/21/18
08:05
Recommendations
Voyager Therapeutics, AbbVie analyst commentary  »

Voyager Therapeutics…

VYGR

Voyager Therapeutics

$23.66

4.3 (22.21%)

ABBV

AbbVie

$117.98

-0.62 (-0.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Mar

CATS

Catasys

$4.37

0.05 (1.16%)

08:05
02/21/18
02/21
08:05
02/21/18
08:05
Hot Stocks
Catasys announces launch of enrollment with national health insurer »

Catasys announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:05
02/21/18
02/21
08:05
02/21/18
08:05
General news
Fedspeak resumes after a hiatus: »

Fedspeak resumes after a…

CQH

Cheniere Energy Partners LP

$28.11

0.11 (0.39%)

08:03
02/21/18
02/21
08:03
02/21/18
08:03
Hot Stocks
Breaking Hot Stocks news story on Cheniere Energy Partners LP »

Cheniere Energy Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

MTCH

Match Group

$42.10

0.54 (1.30%)

08:03
02/21/18
02/21
08:03
02/21/18
08:03
Technical Analysis
Technical Take: Match Group slides in early trading, analyst action »

The stock was last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MO

Altria Group

$64.19

-1.27 (-1.94%)

08:03
02/21/18
02/21
08:03
02/21/18
08:03
Earnings
Altria Group reaffirms FY18 adjusted EPS view $3.90-$4.03, consensus $4.01 »

Altria reaffirms its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

CQH

Cheniere Energy Partners LP

$28.11

0.11 (0.39%)

08:03
02/21/18
02/21
08:03
02/21/18
08:03
Earnings
Breaking Earnings news story on Cheniere Energy Partners LP »

Cheniere Energy Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

ABBV

AbbVie

$117.98

-0.62 (-0.52%)

, NBIX

Neurocrine

$84.58

-0.67 (-0.79%)

08:03
02/21/18
02/21
08:03
02/21/18
08:03
Hot Stocks
AbbVie: Phase 3 ELARIS UF-I study of elagolix met primary endpoint »

AbbVie (ABBV) in…

ABBV

AbbVie

$117.98

-0.62 (-0.52%)

NBIX

Neurocrine

$84.58

-0.67 (-0.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Mar

VG

Vonage

$11.47

0.28 (2.50%)

08:03
02/21/18
02/21
08:03
02/21/18
08:03
Earnings
Vonage sees 2018 revenue $1.03B-$1.05B, consensus $1.03B »

Sees 2018 Capex of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 14

    Mar

CQP

Cheniere Energy Partners

$29.65

0.48 (1.65%)

08:02
02/21/18
02/21
08:02
02/21/18
08:02
Earnings
Breaking Earnings news story on Cheniere Energy Partners »

Cheniere Energy Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

CQP

Cheniere Energy Partners

$29.65

0.48 (1.65%)

08:02
02/21/18
02/21
08:02
02/21/18
08:02
Earnings
Breaking Earnings news story on Cheniere Energy Partners »

Cheniere Energy Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

VG

Vonage

$11.47

0.28 (2.50%)

08:02
02/21/18
02/21
08:02
02/21/18
08:02
Earnings
Vonage reports Q4 adjusted EPS 9c, consensus 9c »

Reports Q4 revenue $254M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 14

    Mar

PANW

Palo Alto Networks

$162.92

0.84 (0.52%)

08:01
02/21/18
02/21
08:01
02/21/18
08:01
Upgrade
Palo Alto Networks rating change  »

Palo Alto Networks…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 26

    Feb

  • 04

    Mar

  • 14

    Mar

ANY

Sphere 3D

$2.34

0.0101 (0.43%)

08:00
02/21/18
02/21
08:00
02/21/18
08:00
Hot Stocks
Breaking Hot Stocks news story on Sphere 3D »

Sphere 3D trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:00
02/21/18
02/21
08:00
02/21/18
08:00
General news
U.S. chain store sales fell 0.6% to 115.8 in the week ended February 17 »

U.S. chain store sales…

DPZ

Domino's Pizza

$221.49

0.75 (0.34%)

07:59
02/21/18
02/21
07:59
02/21/18
07:59
Recommendations
Domino's Pizza analyst commentary  »

Domino's Pizza price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 30

    May

IPHI

Inphi

$25.20

0.76 (3.11%)

07:59
02/21/18
02/21
07:59
02/21/18
07:59
Recommendations
Inphi analyst commentary  »

Inphi weakness a buying…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

NTDOY

Nintendo

$54.25

0.1 (0.18%)

07:59
02/21/18
02/21
07:59
02/21/18
07:59
Periodicals
Nintendo accused of illegally denying refunds on pre-orders, TechCrunch says »

Nintendo has been accused…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SSTI

ShotSpotter

$20.00

0.03 (0.15%)

07:58
02/21/18
02/21
07:58
02/21/18
07:58
Earnings
ShotSpotter raises FY18 revenue view to $31M-$33M from $30M-$32M »

ShotSpotter expects FY18…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.